Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1
Nobukazu Fujimoto(Okayama Rosai Hospital), H. Fujiki, Shigeo Okabe, Masami Suganuma(Saitama University), M. Harada, E. Sueoka, Naoko Sueoka(Saitama Cancer Center)
Cited by 38
Related Papers
Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR
|Journal of Cancer Research and Clinical Oncology|1992|807
Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter.
|Proceedings of the National Academy of Sciences|1988|602
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)
|Annals of Oncology|2012|555
Preventive effects of drinking green tea on cancer and cardiovascular disease: Epidemiological evidence for multiple targeting prevention
|BioFactors|2000|408
Tumor Promotion by Inhibitors of ProteinZ Phosphatases 1 and 2A: The Okadaic Acid Class of Compounds
|Advances in cancer research|1993|310